Affle 3i Limited: Q1 FY2027 Revenue Jumps 20.4% to ₹7,472 Million

Affle 3i Limited has announced its financial results for the first quarter ended June 30, 2026. The company reported a notable 20.4% year-over-year increase in revenue, reaching ₹7,472 million. EBITDA grew by 20.0% to ₹1,676 million, and Profit After Tax (PAT) saw a 21.7% rise to ₹1,284 million, indicating robust operational performance and profitable growth during the period.

Affle 3i Limited Reports Strong Q1 FY2027 Performance

Affle 3i Limited, a global technology company, has released its unaudited consolidated financial results for the first quarter ended June 30, 2026. The company has demonstrated significant growth across key financial metrics, reinforcing its market position.

Key Financial Highlights

In the year-over-year comparison for Q1 FY2027 versus Q1 FY2026:

  • Revenue from Contracts with Customers increased by 20.4% to ₹7,472 million from ₹6,207 million.
  • EBITDA grew by 20.0% to ₹1,676 million from ₹1,397 million. The EBITDA margin stood at 22.4%.
  • Profit After Tax (PAT) surged by 21.7% to ₹1,284 million from ₹1,055 million. The PAT margin improved to 16.6%.

Quarter-over-Quarter Performance

On a quarter-over-quarter basis (Q1 FY2027 vs. Q4 FY2026):

  • Revenue saw a 3.1% increase, reaching ₹7,472 million.
  • EBITDA increased by 4.0% to ₹1,676 million.
  • PAT rose by 7.5% to ₹1,284 million.

Business and Operational Insights

The presentation also highlighted Affle’s vision for 10x Decadal Growth driven by innovation, impact, and intelligence. The company’s CPCU (Cost Per Converted User) business continues to be the primary revenue driver, contributing 99.8% of revenue in Q1 FY2027. Performance across verticalized categories and geographies shows consistent growth, with India & Emerging Markets contributing 72.2% and Developed Markets 27.8% of revenue in Q1 FY2027.

The company also provided insights into its asset and liability position as of June 30, 2026, with total assets amounting to ₹48,316 million and total equity & liabilities also at ₹48,316 million. Operating cash flows for FY2026 stood at ₹5,023 million.

Source: BSE

Previous Article

Affle: Q1 FY27 Standalone Revenue ₹2,396 Crore, Consolidated ₹7,471 Crore

Next Article

Akums Drugs: Q1 FY27 Investor Presentation Highlights Revenue Growth & Acquisition